Literature DB >> 17063568

Inhaled corticosteroids and mortality in COPD.

D D Sin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17063568      PMCID： PMC2104754     

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  14 in total

1.  Inhaled corticosteroids and mortality in COPD: are we there yet?

Authors:  R Stirling
Journal:  Thorax       Date:  2006-08       Impact factor: 9.139

2.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial.

Authors:  P S Burge; P M Calverley; P W Jones; S Spencer; J A Anderson; T K Maslen
Journal:  BMJ       Date:  2000-05-13

3.  Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids.

Authors:  A M Schols; G Wesseling; A D Kester; G de Vries; R Mostert; J Slangen; E F Wouters
Journal:  Eur Respir J       Date:  2001-03       Impact factor: 16.671

4.  C-reactive protein in patients with COPD, control smokers and non-smokers.

Authors:  V M Pinto-Plata; H Müllerova; J F Toso; M Feudjo-Tepie; J B Soriano; R S Vessey; B R Celli
Journal:  Thorax       Date:  2005-09-02       Impact factor: 9.139

5.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.

Authors:  Robert Wise; John Connett; Gail Weinmann; Paul Scanlon; Melissa Skeans
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

6.  Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease.

Authors:  D D Sin; L Wu; J A Anderson; N R Anthonisen; A S Buist; P S Burge; P M Calverley; J E Connett; B Lindmark; R A Pauwels; D S Postma; J B Soriano; W Szafranski; J Vestbo
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

Review 7.  The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials.

Authors:  Abdullah Alsaeedi; Don D Sin; Finlay A McAlister
Journal:  Am J Med       Date:  2002-07       Impact factor: 4.965

Review 8.  Contemporary management of chronic obstructive pulmonary disease: scientific review.

Authors:  Don D Sin; Finlay A McAlister; S F Paul Man; Nick R Anthonisen
Journal:  JAMA       Date:  2003-11-05       Impact factor: 56.272

9.  The nature of small-airway obstruction in chronic obstructive pulmonary disease.

Authors:  James C Hogg; Fanny Chu; Soraya Utokaparch; Ryan Woods; W Mark Elliott; Liliana Buzatu; Ruben M Cherniack; Robert M Rogers; Frank C Sciurba; Harvey O Coxson; Peter D Paré
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

10.  Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease.

Authors:  Don D Sin; S F Paul Man
Journal:  Circulation       Date:  2003-03-25       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.